This rise can be attributed to several factors, including aging populations, the obesity epidemic, and dietary influences such as higher purine consumption and increased alcohol intake. Innovations in urate-lowering therapies and biologic agents are providing patients with more effective treatment options compared to traditional medications like allopurinol and colchicine.